Pharmacodynamic Parameters of Two Different Doses of Cefepime
NCT00177736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2007-12-13
Summary
Pharmacokinetics is the study of the disposition of drugs in the body, while pharmacodynamics considers the interaction of the drug at the site of infection over time. Mathematical models of antibiotic pharmacodynamics are sometimes used to predict if antibiotic doses are sufficient to treat infection with organisms of different minimal inhibitory concentrations of the antibiotic. Based on these models, there has been speculation that the antibiotic cefepime dosed at one gram every 12 hours, is insufficient to kill all organisms within the "susceptible" range. This study of patients treated with cefepime will involve the collection of blood to determine cefepime concentrations, and determine if those concentrations are effective in killing the bacteria at the site of infection.
Conditions
Sponsors & Collaborators
-
Elan Pharmaceuticals
collaborator INDUSTRY -
University of Pittsburgh
lead OTHER
Principal Investigators
-
David L Paterson, MD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
NCT02596984 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
NCT01401010 ·Status: COMPLETED ·Phase: PHASE4
-
Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokinetics Model
NCT03683511 ·Status: COMPLETED
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular Infections
NCT03134521 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy
NCT00214331 ·Status: COMPLETED
-
Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections
NCT03209921 ·Status: COMPLETED
-
Population Pharmacokinetics of Anti-infectives in Hospitalized Patients
NCT02998411 ·Status: RECRUITING
-
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
NCT03078010 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
NCT01030731 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants
NCT00942149 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients
NCT02993575 ·Status: COMPLETED
-
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT03790631 ·Status: COMPLETED
-
Prolonged Infusion Cefepime and Nosocomial Infections
NCT02568800 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.
NCT04470973 ·Status: UNKNOWN
-
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
NCT00771719 ·Status: TERMINATED ·Phase: PHASE1
-
Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility
NCT04083443 ·Status: UNKNOWN
-
Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients
NCT01157533 ·Status: TERMINATED ·Phase: NA
-
Personalized Optimization of Antibiotic Therapy in Pulmonary Sepsis Critically Ill Patients Through Application of Rapid Microbiological Diagnostic Technologies and Pharmacokinetic/Pharmacodynamic Modelling
NCT06956053 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate Sodium
NCT02288429 ·Status: COMPLETED
-
Pharmacokinetics of Caspofungin
NCT03399032 ·Status: COMPLETED
-
Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
NCT05950984 ·Status: COMPLETED
-
TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates
NCT01319435 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
NCT00873327 ·Status: COMPLETED ·Phase: PHASE1